Moxibustion in the management of irritable bowel syndrome: Systematic review and meta-analysis

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Park, Jae Woo ^a   Lee, Byung Hee ^b   Lee, Hyangsook ^a,b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ACUPUNCTURE; ARTICLE; CHINA; CINAHL; COCHRANE LIBRARY; EMBASE; HERBAL MEDICINE; HUMAN; INTERMETHOD COMPARISON; IRRITABLE COLON; MEDLINE; META ANALYSIS; MOXIBUSTION; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MOXIBUSTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84884784338     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-247     Document Type: Article

References (57)

1. Ford A, Vandvik P. Irritable bowel syndrome. Clin Evid 2010, 1:410.
2. Brandt L, Chey W, Foxx-Orenstein A, Schiller L, Schoenfeld P, Spiegel B, Talley N, Quigley E, . American College of Gastroenterology Task Force on Irritable Bowel Syndrome An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009, 104:S1-S35. American College of Gastroenterology Task Force on Irritable Bowel Syndrome.
3. Ford A, Talley N. IBS in 2010: advances in pathophysiology, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 2011, 8:76-78. 10.1038/nrgastro.2010.216, 21293507.
4. Magge S, Lembo A. Complementary and alternative medicine for the irritable bowel syndrome. Gastroenterol Clin North Am 2011, 40:245-253. 10.1016/j.gtc.2010.12.005, 21333910.
5. Barnes P, Bloom B, Nahin R. Complementary and alternative medicine use among adults and children: United States, 2007. National health statistics reports; no 12 2008, Hyattsville, MD: National Center for Health Statistics.
6. Ouyang H, Chen JDZ. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004, 20:831-841. 10.1111/j.1365-2036.2004.02196.x, 15479354.
7. World Health Organization Western Pacific Region WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region 2007, World Health Organization Western Pacific: Manila, Philippines, World Health Organization Western Pacific Region.
8. Lee MS, Kang JW, Ernst E. Does moxibustion work? An overview of systematic reviews. BMC Res Notes 2010, 3:284. 10.1186/1756-0500-3-284, 2987875, 21054851.
9. Manheimer E, Wieland LS, Cheng K, Li SM, Shen X, Berman BM, Lao L. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2012, 107:835-847. quiz 848, 10.1038/ajg.2012.66, 3671917, 22488079.
10. Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, Lao L. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2012, 5. CD005111.
11. Higgins J, Altman D. Chapter 8: assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions 2008, 187-241. Chichester: The Cochrane Collaboration and John Wiley & Sons Ltd, Higgins J, Green S.
12. Deeks J, Higgins J, Altman D. Chapter 9: analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions 2008, 243-296. Chichester: The Cochrane Collaboration and John Wiley & Sons Ltd, Higgins J, Green S.
13. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558. 10.1002/sim.1186, 12111919.
14. Carroll D, Tramèr M, McQuay H, Nye B, Moore A. Randomization is important in studies with pain outcomes: systematic review of transcutaneous electrical nerve stimulation in acute postoperative pain. Br J Anaesth 1996, 77:798-803. 10.1093/bja/77.6.798, 9014639.
15. Pildal J, Hróbjartsson A, Jørgensen K, Hilden J, Altman D, Gøtzsche P. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007, 36(4):847-857. 10.1093/ije/dym087, 17517809.
16. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011, 8. CD003460.
17. An G, Li N, Zhai G, Liu H, Sun J, Liang H, Xu R. Evaluation of the therapeutic effect of acupuncture and moxibustion on irritable bowel syndrome [in Chinese]. Shanghai J Acupunct Moxibustion 2010, 29(6):354-356.
18. Anastasi JK, McMahon DJ, Kim GH. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion. Gastroenterol Nurs 2009, 32(4):243-255. 10.1097/SGA.0b013e3181b2c920, 19696601.
19. Chen Q. Clinical study on irritable bowel syndrome of diarrhea type with Chang-three-needle technique [in Chinese] 2011, Guangzhou university of Chinese medicine, Guangzhou.
20. Chu H, Huang X, Li X, Cheng H, Ding Y. Moxibustion for diarrhea-type irritable bowel syndrome: a clinical study [in Chinese]. J Anhui Trad Chin Med Coll 2011, 30(6):33-36.
21. Hu D, Kang M, Xiong J, Deng P. Irritable bowel syndrome with diarrhea (IBS-D) treated with moxibustion on heat-sensitive acupoints: a randomized controlled trial. World J Acupunct-Moxibustion 2012, 22(2):1-5.
22. Huang Z, Jin H. A study on the improved therapeutic effect of colon hydrotherapy combined with moxibustion on irritable bowel syndrome [in Chinese]. Chin J Integr Trad West Med Dig 2007, 15(5):330-331.
23. Jiang J, Zhao N, Xu J, Wang H. The efficacy observation of trimebutine with ginger partitioned moxibustion for diarrhea-predominant irritable bowel syndrome (IBS-D) [in Chinese]. Shenzhen J Integr Trad Chin West Med 2010, 20(4):239-241.
24. Liu G. Observation of treatment effect of acupuncture and moxibustion plus psychotherapy for irritable bowel syndrome [in Chinese]. Zhongguo Zhenjiu 1997, 17(10):611-612.
25. Luo S, Chen C. Clinical observation of therapeutic effect of thunderbolt moxibustion on constipation-predominant irritable bowel syndrome (IBS-C) [in Chinese]. Guangxi J Trad Chin Med 2011, 34(5):268-269.
26. Luo S, Chen C. Shuxiangjiu (sparse incense moxibustion) for treatment of constipation-predominant irritable bowel syndrome (IBS-C) of stagnation of liver-qi stagnation type patient's curative effect observation [in Chinese]. Guiding J Trad Chin Med Pharmacy 2012, 18(1):51-52.
27. Luo S, Long J, Huang L. The curative effect observation and nursing of moxibustion combined with pinaverium bromide tablets to cure abdominal pain and diarrhea intestine irritable syndrome [in Chinese]. J Jinggangshan Med Coll 2008, 15(4):39-40.
28. Ni Y, Lu J. Clinical research on moxibustion treatment of diarrhea type irritable bowel syndrome [in Chinese]. World J Acupunct-Moxibustion 2001, 11(3):19-23.
29. Shang Z, Xu M, Tian L. Acupuncture combined with moxibustion in the treatment of 48 patients with diarrhea-predominant irritable bowel syndrome [in Chinese]. China Med Herald 2012, 9(3):96-97.
30. Wang J, He D, Kuang Y. Combination of Chinese herbal medicine and moxibustion treatment in 30 cases of diarrhea-predominant irritable bowel syndrome (IBS-D) [in Chinese]. J New Chin Med 2009, 41(3):82.
31. Wang W. Clinical observation of warm needling treatment for diarrhea-predominant irritable bowel syndrome (IBS-D) [in Chinese]. J Emerg Trad Chin Med 2008, 17(10):1377-1407.
32. Wu H, Wang J, Chen H, Hua X, Shi Z. The therapeutic effect and immunological mechanism of herbs-partition moxibustion in treating irritable bowel syndrome. Zhongguo Zhenjiu 1996, 16(2):43-45.
33. Xiong X, Lin Y. Acupuncture plus traditional Chinese herbal medicine in treating 42 patients with diarrhea-predominant irritable bowel syndrome (IBS-D) [in Chinese]. J Fujian Univ Trad Chin Med 2008, 18(2):38-40.
34. Xue Y, Tian X. A clinical research of the effect of acupuncture and its relationship between free radicals and irritable bowel syndrome [in Chinese]. Chin Arch Trad Chin Med 2009, 27(1):111-112.
35. Zeng Y, Bao Y, Chu J, Li H, Zhu G, Zhang W. Effect of moxibustion on diarrhea-dominant irritable bowel syndrome (IBS-D) patients in dog days [in Chinese]. Chin Arch Trad Chin Med 2010, 28(8):1774-1776.
36. Zhang Y, Yan C, Xie S. Ginger-partitioned moxibustion at CV8 treatment for 30 cases of diarrhea-predominant irritable bowel syndrome (IBS-D) [in Chinese]. Jiangxi J Trad Chin Med 2007, 8:69-70.
37. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche P, Ioannidis J, Clarke M, Devereaux P, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700. 10.1136/bmj.b2700, 2714672, 19622552.
38. MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, Moher D, . On behalf of the STRICTA revision group Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010, 7:e1000261. 10.1371/journal.pmed.1000261, 2882429, 20543992, On behalf of the STRICTA revision group.
39. Irvine E, Whitehead W, Chey W, Matsueda K, Shaw M, Talley N, Veldhuyzen van Zanten S, . Design of Treatment Trials Committee Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006, 130(5):1538-1551. 10.1053/j.gastro.2005.11.058, 16678567, Design of Treatment Trials Committee.
40. Odgaard-Jensen J, Vist G, Timmer A, Kunz R, Akl E, Schünemann H, Briel M, Nordmann A, Pregno S, Oxman A. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2011, 4. MR000012.
41. Sedgwick P. Allocation concealment. BMJ 2012, 344(e156). doi:10.1136/bmj.e156.
42. Spiller R. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience form published trials. Am J Med 1999, 107(5A):91S-97S.
43. Zhao B, Wang X, Lin Z, Liu R, Lao L. A novel sham moxibustion device: a randomized, placebo-controlled trial. Complement Ther Med 2006, 14(1):53-60. 10.1016/j.ctim.2005.06.003, 16473754.
44. Pham B, Klassen T, Lawson M, Moher D. Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary. J Clin Epidemiol 2005, 58(8):769-776. 10.1016/j.jclinepi.2004.08.021, 16086467.
45. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998, 19(2):159-166. 10.1016/S0197-2456(97)00150-5, 9551280.
46. Tang J, Zhan S, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ 1999, 319(7203):160-161. 10.1136/bmj.319.7203.160, 28166, 10406751.
47. Egger M, Jüni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 2003, 7:1-76.
48. Thompson SG. Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994, 309(6965):1351-1355. 10.1136/bmj.309.6965.1351, 2541868, 7866085.
49. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
50. Dixon-Woods M, Critchley S. Medical and lay views of irritable bowel syndrome. Fam Pract 2000, 17(2):108-113. 10.1093/fampra/17.2.108, 10758070.
51. Ford A, Brandt L, Young C, Chey W, Foxx-Orenstein A, Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009, 104:1831-1843. 10.1038/ajg.2009.223, 19471254.
52. MacPherson H, Tilbrook H, Bland M, Bloor K, Brabyn S, Cox H, Kang'ombe A, Man M, Stuardi T, Torgerson D, et al. Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial. BMC Gastroenterol 2012, 12(1):150. 10.1186/1471-230X-12-150, 3556159, 23095376.
53. Park JE, Lee SS, Lee MS, Choi SM, Ernst E. Adverse events of moxibustion: a systematic review. Complement Ther Med 2010, 18(5):215-223. 10.1016/j.ctim.2010.07.001, 21056845.
54. Koo S, Kim S, Park H, Shin S, Lee S, Jang I, Chae H, Chae Y. A guide to safe acupuncture and moxibustion practice 2011, Seoul: Koonja publishing.
55. Kim SY, Lee H, Chae Y, Park HJ, Lee H. A systematic review of cost-effectiveness analyses alongside randomised controlled trials of acupuncture. Acupunct Med 2012, doi:10.1136/acupmed-2012-010178.
56. van den Berg I, Kaandorp GC, Bosch JL, Duvekot JJ, Arends LR, Hunink MGM. Cost-effectiveness of breech version by acupuncture-type interventions on BL 67, including moxibustion, for women with a breech foetus at 33 weeks gestation: a modelling approach. Complement Ther Med 2010, 18(2):67-77. 10.1016/j.ctim.2010.01.003, 20430289.
57. Stamuli E, Bloor K, MacPherson H, Tilbrook H, Stuardi T, Brabyn S, Torgerson D. Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care. BMC Gastroenterol 2012, 12(1):149. 10.1186/1471-230X-12-149, 3579701, 23095351.